Seneca Therapeutics, Inc. — Form D

Seneca Therapeutics, Inc. of BLUE BELL, PA, a company, filed a Form D exempt-offering notice with the SEC on 2025-02-07. The offering totals $8.0M, of which $1.6M was reported sold. Industry: Pharmaceuticals.

Offering

Filed: 2025-02-07
Form: D
Accession: 0001778151-25-000001
Industry: Pharmaceuticals
Exemptions: 06b
Total offering: $8.0M
Amount sold: $1.6M
Remaining: $6.4M
Investors: 68
Date of first sale: 2024-12-16
Security types: equity
Revenue range: Decline to Disclose
SEC file number: 021-537724

Issuer

Name: Seneca Therapeutics, Inc.
CIK: 0001778151
Entity type: Corporation
Jurisdiction: DELAWARE
Incorporated: 2018
Address: 202 ST. ANDREWS COURT, BLUE BELL, PA, 19422
Phone: 484-883-9725

Officers, directors & promoters (8)

Name	Role	Location
Cuong Do	Director	DOYLESTOWN, PA
Paul Hallenbeck	Director	Blue Bell, PA
James Hussey	Director	Austin, TX
Mark Kerschner	Director	Blue Bell, PA
Cuong Do	Executive Officer	DOYLESTOWN, PA
Paul Hallenbeck	Executive Officer	Blue Bell, PA
James Hussey	Executive Officer	Austin, TX
Mark Kerschner	Executive Officer	Blue Bell, PA

Other filings by this issuer (8)

Filed	Form	Offering	Sold
2022-12-23	D/A	$12.8M	$7.7M
2021-12-22	D/A	$10.0M	$5.0M
2021-04-02	D	$5.0M	$727K
2020-06-23	D	$3.3M	$501K
2020-03-19	D/A	$1.0M	$820K
2019-11-22	D	$750K	$65K
2019-08-08	D/A	$500K	$380K
2019-05-30	D	$350K	$55K

More